Design and synthesis of small molecules with enhanced anti-tumor potentialmedorglab26 de set. de 20191 min de leituraKick-off meeting of Bilateral Action FCT/NKFIH and 1st annual meeting of DD4PPIFlyer Ação bilateral.pdfFazer download de PDF • 1.41MB
New published paper "Hybrid Molecules of p53 Activators and Protoflavones to Target Multiple Myeloma" in ChemMedChem
Ricardo Ferreira represented the Medicinal Organic Chemistry group at the 12th edition of the EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2025)
Medicinal Organic Chemistry group represented at the 10th edition of the International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 2025)
Comentários